CME
Diabetic Eye Disease Pipeline Therapies Part 2: High-dose Aflibercept & Gene Therapy
Host: Christina Y. Weng, MD, MBA Guest: Glenn Yiu, MD, PhD This discussion with Program Chair Christina Y. Weng, MD, MBA, and Glenn Yiu, MD, PhD, includes a case study that highlights challenges with managing diabetic eye disease during the